These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32906629)

  • 1. Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.
    Mattoli MV; Treglia G; Calcagni ML; Mangiola A; Anile C; Trevisi G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic spatial covariance pattern of definite idiopathic normal pressure hydrocephalus: an FDG PET study with principal components analysis.
    Rau A; Schröter N; Blazhenets G; Maurer C; Urbach H; Meyer PT; Frings L
    Alzheimers Res Ther; 2023 Nov; 15(1):202. PubMed ID: 37980531
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Townley RA; Botha H; Graff-Radford J; Boeve BF; Petersen RC; Senjem ML; Knopman DS; Lowe V; Jack CR; Jones DT
    Neuroimage Clin; 2018; 18():897-902. PubMed ID: 29876274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
    J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus.
    Hiraoka K; Narita W; Kikuchi H; Baba T; Kanno S; Iizuka O; Tashiro M; Furumoto S; Okamura N; Furukawa K; Arai H; Iwata R; Mori E; Yanai K
    J Neurol Sci; 2015 Sep; 356(1-2):124-8. PubMed ID: 26095458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
    J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct cerebral cortical perfusion patterns in idiopathic normal-pressure hydrocephalus.
    Kang K; Jeong SY; Park KS; Hahm MH; Kim J; Lee HW; Kim CH; Yun E; Han J; Yoon U; Lee SW
    Hum Brain Mapp; 2023 Jan; 44(1):269-279. PubMed ID: 36102811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus.
    Rinne JO; Suotunen T; Rummukainen J; Herukka SK; Nerg O; Koivisto AM; Rauramaa T; Någren K; Hiltunen M; Alafuzoff I; Rinne J; Jääskeläinen JE; Soininen H; Leinonen V
    J Alzheimers Dis; 2019; 67(4):1343-1351. PubMed ID: 30689567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of amyloid PET in patient selection for extra-ventricular shunt insertion for the treatment of idiopathic normal pressure hydrocephalus: A pooled analysis.
    Mallon DH; Malhotra P; Naik M; Edison P; Perry R; Carswell C; Win Z
    J Clin Neurosci; 2021 Aug; 90():325-331. PubMed ID: 34275571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical metabolic changes and clinical outcome in normal pressure hydrocephalus after ventriculoperitoneal shunt: Our preliminary results.
    Chiaravalloti A; Filippi L; Bagni O; Schillaci O; Czosnyka Z; Czosnyka M; de Pandis MF; Federici G; Galli M; Pompucci A; Petrella G
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):367-374. PubMed ID: 32660834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of perfusion deficit with early phases of [
    Völter F; Beyer L; Eckenweber F; Scheifele M; Bui N; Patt M; Barthel H; Katzdobler S; Palleis C; Franzmeier N; Levin J; Perneczky R; Rauchmann BS; Sabri O; Hong J; Cumming P; Rominger A; Shi K; Bartenstein P; Brendel M
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1384-1394. PubMed ID: 36572740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
    Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
    Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
    Carneiro CG; Faria DP; Coutinho AM; Ono CR; Duran FLS; da Costa NA; Garcez AT; da Silveira PS; Forlenza OV; Brucki SMD; Nitrini R; Busatto G; Buchpiguel CA
    Braz J Psychiatry; 2022 Aug; 44(5):495-506. PubMed ID: 36420910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain positron emission tomography in idiopathic normal-pressure hydrocephalus: new 18 F-fluorodeoxyglucose pattern in a long-known syndrome.
    Cistaro A; Quartuccio N; Piccardo A; Meo G; Gandoglia I; Schiera IG; Fania P; Lupidi F; Bottoni G; Massollo M; Altrinetti V; Pestarino E; Iacozzi M; Iantorno M; Del Sette M
    Nucl Med Commun; 2023 Dec; 44(12):1163-1167. PubMed ID: 37779439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer's disease.
    Kondo M; Tokuda T; Itsukage M; Kuriyama N; Matsushima S; Yamada K; Nakanishi H; Ishikawa M; Nakagawa M
    Neuroradiol J; 2013 Feb; 26(1):41-6. PubMed ID: 23859166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter brain perfusion SPECT study evaluating idiopathic normal-pressure hydrocephalus on neurological improvement.
    Ishii K; Hashimoto M; Hayashida K; Hashikawa K; Chang CC; Nakagawara J; Nakayama T; Mori S; Sakakibara R
    Dement Geriatr Cogn Disord; 2011; 32(1):1-10. PubMed ID: 21811073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.